Plain-English translation of NCT06523647 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Crohn's Disease research guide →This trial is observing how well Ustekinumab works for people with Crohn's disease. Researchers will look at both past medical records and collect new information going forward to understand how effective this medication is at helping patients feel better and manage their condition.
Doctors need real-world evidence about how this medication performs in everyday clinical practice—not just in controlled research settings—so they can better understand which patients benefit most from the treatment.
You would allow the research team to review your medical records from before and after you started the medication to track how you respond to treatment. The study has both a look-back component (reviewing past records) and a forward-looking component (monitoring you going forward), so researchers can see the full picture of how well the medication is working for you over time.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Kazakhstan
Sponsor
Kazakhstan Scientific Society for Study of intestine diseases
Enrollment target
~150 participants
Started
June 2023
Primary completion
December 2025
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kanat Khazhidinov
Kazakhstan Scientific Society for Study of intestine diseases